KDventures AB (FRA:2I9)

Market Cap	14.79M -38.5%
Revenue (ttm)	142.44K -17.9%
Net Income	-19.48M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0752
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About KDventures AB

KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2I9

Financial Performance

In 2025, KDventures AB's revenue was 1.67 million, a decrease of -9.09% compared to the previous year's 1.84 million. Losses were -193.86 million, 2293.0% more than in 2024.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error